Preventing overdoses in supportive housing for the homeless
Implementation of Overdose Prevention Practices in Permanent Supportive Housing
This study is all about finding better ways to keep people safe from overdoses in supportive housing, where tenants may be at higher risk, by trying out helpful tools and strategies in 20 buildings across New York.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11051118 on NIH RePORTER |
What this research studies
This research focuses on implementing overdose prevention practices in permanent supportive housing (PSH) to protect tenants who are at high risk for overdose due to various factors. The project involves adapting evidence-based practices specifically for the unique environment of PSH and testing their implementation across 20 PSH buildings in New York. Key strategies include creating a toolkit for staff and tenants, establishing partnerships for support, and evaluating the effectiveness of these practices in real-world settings. The goal is to enhance safety and health outcomes for individuals living in supportive housing.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals residing in permanent supportive housing who are at risk for overdose.
Not a fit: Patients who do not reside in supportive housing or are not at risk for overdose may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of overdoses among individuals living in supportive housing.
How similar studies have performed: Previous research has shown success in implementing similar overdose prevention strategies in various community settings, indicating potential for effectiveness in this context.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Doran, Kelly — New York University School of Medicine
- Study coordinator: Doran, Kelly
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.